Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells

被引:30
|
作者
Wu, Hao [1 ,2 ,3 ]
Weidinger, Carl [1 ]
Schmidt, Franziska [1 ,3 ]
Keye, Jacqueline [1 ,3 ]
Friedrich, Marie [1 ,3 ]
Yerinde, Cansu [1 ]
Willimsky, Gerald [5 ,6 ]
Qin, Zhihai [2 ,4 ]
Siegmund, Britta [1 ]
Glauben, Rainer [1 ]
机构
[1] Charite, Med Dept Gastroenterol Infect Dis & Rheumatol, D-12200 Berlin, Germany
[2] Zhengzhou Univ, Affiliated Hosp 1, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[3] Free Univ Berlin, Dept Biol Chem & Pharm, D-14195 Berlin, Germany
[4] Chinese Acad Sci, Inst Biophys, Key Lab Prot & Peptide Pharmaceut, Beijing 100101, Peoples R China
[5] Charite, Inst Immunol, D-13125 Berlin, Germany
[6] German Canc Res Ctr, D-69120 Heidelberg, Germany
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
HISTONE DEACETYLASE INHIBITORS; FREE FATTY-ACID; ADIPOSE-TISSUE; RECEPTOR EXPRESSION; IN-VITRO; CANCER; MACROPHAGES; ACTIVATION; MECHANISMS; RESPONSES;
D O I
10.1038/s41598-017-07685-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumor infiltrating myeloid cells play contradictory roles in the tumor development. Dendritic cells and classical activated macrophages support anti-tumor immune activity via antigen presentation and induction of pro-inflammatory immune responses. Myeloid suppressor cells (MSCs), for instance myeloid derived suppressor cells (MDSCs) or tumor associated macrophages play a critical role in tumor growth. Here, treatment with sodium oleate, an unsaturated fatty acid, induced a regulatory phenotype in the myeloid suppressor cell line MSC-2 and resulted in an increased suppression of activated T cells, paralleled by increased intracellular lipid droplets formation. Furthermore, sodium oleate potentiated nitric oxide (NO) production in MSC-2, thereby increasing their suppressive capacity. In primary polarized bone marrow cells, sodium oleate (C18:1) and linoleate (C18:2), but not stearate (C18:0) were identified as potent FFA to induce a regulatory phenotype. This effect was abrogated in MSC-2 as well as primary cells by specific inhibition of droplets formation while the inhibition of de novo FFA synthesis proved ineffective, suggesting a critical role for exogenous FFA in the functional induction of MSCs. Taken together our data introduce a new unsaturated fatty acid-dependent pathway shaping the functional phenotype of MSCs, facilitating the tumor escape from the immune system.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
    Siret, Carole
    Collignon, Aurelie
    Silvy, Francoise
    Robert, Stephane
    Cheyrol, Thierry
    Andre, Perrine
    Rigot, Veronique
    Iovanna, Juan
    van de Pavert, Serge
    Lombardo, Dominique
    Mas, Eric
    Martirosyan, Anna
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [42] Prevalence and prognostic significance of myeloid-derived suppressor cells and regulatory T cells in pancreatic and esophagogastric cancer
    Gabitass, R. F.
    Annels, N. E.
    Pandha, H. S.
    Middleton, A. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
    Fujimura, Taku
    Kambayashi, Yumi
    Aiba, Setsuya
    ONCOIMMUNOLOGY, 2012, 1 (08): : 1433 - 1434
  • [44] Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
    Kittang, Astrid Olsnes
    Kordasti, Shahram
    Sand, Kristoffer Evebo
    Costantini, Benedetta
    Kramer, Anne Marijn
    Perezabellan, Pilar
    Seidl, Thomas
    Rye, Kristin Paulsen
    Hagen, Karen Marie
    Kulasekararaj, Austin
    Bruserud, Oystein
    Mufti, Ghulam J.
    ONCOIMMUNOLOGY, 2016, 5 (02):
  • [45] Myeloid derived suppressor cells in transplantation
    Lees, Jason R.
    Azimzadeh, Agnes M.
    Bromberg, Jonathan S.
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (05) : 692 - 697
  • [46] Myeloid-derived suppressor cells
    Nagaraj, Srinivas
    Gabrilovich, Dmitry I.
    IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 213 - 223
  • [47] Myeloid-Derived Suppressor Cells
    Gabrilovich, Dmitry I.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (01) : 3 - 8
  • [48] Myeloid derived suppressor cells and autoimmunity
    Boros, Peter
    Ochando, Jordi
    Zeher, Margit
    HUMAN IMMUNOLOGY, 2016, 77 (08) : 631 - 636
  • [49] The dual personality of myeloid suppressor cells
    Minton, Kirsty
    NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) : 792 - 792
  • [50] Myeloid-Derived Suppressor Cells
    Woodland, David L.
    VIRAL IMMUNOLOGY, 2017, 30 (02) : 81 - 81